Clinical presentation and natural history of patients with essential thrombocythemia and the Philadelphia chromosome

Six women presented with the clinical picture of essential thrombocythemia (ET) without the anemia, marked splenomegaly, and extreme leukocytosis characteristic of chronic myelogenous leukemia (CML). All had the Philadelphia chromosome on karyotype analysis of the bone marrow. Peripheral basophilia was present in four cases, providing a clinical clue that the Philadelphia chromosome might be present. Marrow biopsy showed granulocytic hyperplasia and either small megakaryocytes or sheets of megakaryocytes with marked atypia, findings that are more typical of CML than ET. The clinical importance of finding the Philadelphia chromosome in patients who seem to have ET is in assessing prognosis. ET generally follows a chronic, indolent course. However, five of these six patients who had the Philadelphia chromosome underwent clinical transition to the accelerated phase of CML or blastic leukemia in 4–7 years.

[1]  J. Curtis,et al.  Essential Thrombocythemia and Leukemic Transformation , 1986, Medicine.

[2]  A. Verhest,et al.  Philadelphia chromosome-positive thrombocythemia with leukemic transformation. , 1983, The New England journal of medicine.

[3]  S. Geller,et al.  Acute leukemia as a natural sequel to primary thrombocythemia. , 1982, American journal of clinical pathology.

[4]  G. Faguet,et al.  Evidence that essential thrombocythemia is a clonal disorder with origin in a multipotent stem cell , 1981 .

[5]  P. H. Fitzgerald,et al.  A Complex Ph1 Translocation in a Patient with Primary Thrombocythaemia , 1981, British journal of haematology.

[6]  J. Goldberg,et al.  Increased incidence of acute leukemia in polycythemia vera associated with chlorambucil therapy. , 1981, The New England journal of medicine.

[7]  T. Papayannopoulou,et al.  Chronic myelocytic leukemia: clonal origin in a stem cell common to the granulocyte, erythrocyte, platelet and monocyte/macrophage. , 1977, The American journal of medicine.

[8]  B. Ridell,et al.  Megakaryocyte quantifications in relation to thrombokinetics in primary thrombocythaemia and allied diseases. , 2009, Scandinavian journal of haematology.

[9]  V. Devita,et al.  Thrombocytosis in chronic granulocytic leukemia: incidence and clinical significance. , 1974, Blood.

[10]  M. Ghosh.  Primary haemorrhagic thrombocythaemia with Philadelphia chromosome , 1972, Postgraduate medical journal.

[11]  M. N. Silverstein.  Primary or hemorrhagic thrombocythemia. , 1968, Archives of internal medicine.

[12]  P. Onesti,et al.  KARYOTYPES IN THROMBOCYTHÆMIA , 1967 .

[13]  H. J. Woodliff,et al.  Cytogenetic studies in megakaryocytic myelosis. , 1967, The Medical journal of Australia.

[14]  S. Krauss.  Chronic myelocytic leukemia with features simulating myelofibrosis with myeloid metaplasia , 1966, Cancer.

[15]  N. H. Kemp,et al.  Chromosome Studies During Early and Terminal Chronic Myeloid Leukaemia , 1964, British medical journal.

[16]  P. Jacobs,et al.  Cytogenetic studies on bone-marrow in chronic myeloid leukaemia. , 1963, Lancet.

[17]  J. Zajicek,et al.  Microplanimetric studies on megakaryocytes in chronic granulocytic leukaemia and polycythaemia vera. , 1961, Acta haematologica.

[18]  W. C. Levin,et al.  Primary hemorrhagic thrombocythemia. , 1960, The American journal of medicine.

[19]  F. Gunz,et al.  Hemorrhagic thrombocythemia: a critical review. , 1960, Blood.

[20]  L. Wasserman,et al.  Leukocyte alkaline phosphatase activity in hematopoietic disorders. A correlative study by biochemical and cytochemical techniques , 1959 .